ZA200701429B - Apparatus components and methods of using apparatus components to detect the presence of an analyte - Google Patents

Apparatus components and methods of using apparatus components to detect the presence of an analyte Download PDF

Info

Publication number: ZA200701429B
Authority: ZA; South Africa
Prior art keywords: antibody; monoclonal anti; aflatoxin; ligands; rigid support
Prior art date: 2004-07-19

Application number

ZA200701429A

Other languages

English (en)

Inventor

Brems Patrick Marcel-Joseph

Van Essche Gonda

Rehmrev-Boom Maria Martha

Original Assignee

Grace Gmbh & Co Kg

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2004-07-19

Filing date

2007-02-19

Publication date

2008-07-30

2007-02-19 Application filed by Grace Gmbh & Co Kg filed Critical Grace Gmbh & Co Kg

2008-07-30 Publication of ZA200701429B publication Critical patent/ZA200701429B/en

Links

238000000034 method Methods 0.000 title claims description 126
239000012491 analyte Substances 0.000 title claims description 56
239000000523 sample Substances 0.000 claims description 178
239000003446 ligand Substances 0.000 claims description 173
239000000758 substrate Substances 0.000 claims description 138
239000003480 eluent Substances 0.000 claims description 82
238000012360 testing method Methods 0.000 claims description 82
239000000463 material Substances 0.000 claims description 66
239000000243 solution Substances 0.000 claims description 57
VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 50
101000882584 Homo sapiens Estrogen receptor Proteins 0.000 claims description 44
239000012530 fluid Substances 0.000 claims description 42
239000005409 aflatoxin Substances 0.000 claims description 39
239000002245 particle Substances 0.000 claims description 29
238000004891 communication Methods 0.000 claims description 28
230000008878 coupling Effects 0.000 claims description 28
238000010168 coupling process Methods 0.000 claims description 28
238000005859 coupling reaction Methods 0.000 claims description 28
OVBPIULPVIDEAO-LBPRGKRZSA-N Folic acid Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 claims description 26
150000001875 compounds Chemical class 0.000 claims description 26
RMRCNWBMXRMIRW-BYFNXCQMSA-M cyanocobalamin Chemical compound N#C[Co+]N([C@]1([H])[C@H](CC(N)=O)[C@]\2(CCC(=O)NC[C@H](C)OP(O)(=O)OC3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)C)C/2=C(C)\C([C@H](C/2(C)C)CCC(N)=O)=N\C\2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O RMRCNWBMXRMIRW-BYFNXCQMSA-M 0.000 claims description 25
235000000639 cyanocobalamin Nutrition 0.000 claims description 25
239000011666 cyanocobalamin Substances 0.000 claims description 25
229960000304 folic acid Drugs 0.000 claims description 25
239000011724 folic acid Substances 0.000 claims description 25
239000011720 vitamin B Substances 0.000 claims description 24
229930195730 Aflatoxin Natural products 0.000 claims description 23
239000007853 buffer solution Substances 0.000 claims description 23
XWIYFDMXXLINPU-UHFFFAOYSA-N Aflatoxin G Chemical compound O=C1OCCC2=C1C(=O)OC1=C2C(OC)=CC2=C1C1C=COC1O2 XWIYFDMXXLINPU-UHFFFAOYSA-N 0.000 claims description 22
-1 pirimifos Chemical compound 0.000 claims description 22
239000002097 aflatoxin B2 Substances 0.000 claims description 20
239000002100 aflatoxin G2 Substances 0.000 claims description 18
IISBACLAFKSPIT-UHFFFAOYSA-N bisphenol A Chemical compound C=1C=C(O)C=CC=1C(C)(C)C1=CC=C(O)C=C1 IISBACLAFKSPIT-UHFFFAOYSA-N 0.000 claims description 17
229960003399 estrone Drugs 0.000 claims description 17
229940011871 estrogen Drugs 0.000 claims description 16
239000000262 estrogen Substances 0.000 claims description 16
125000000524 functional group Chemical group 0.000 claims description 16
229960004719 nandrolone Drugs 0.000 claims description 16
QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims description 15
229930003270 Vitamin B Natural products 0.000 claims description 15
230000003167 anti-vitamin Effects 0.000 claims description 15
239000000741 silica gel Substances 0.000 claims description 15
229910002027 silica gel Inorganic materials 0.000 claims description 15
229960003604 testosterone Drugs 0.000 claims description 15
235000019156 vitamin B Nutrition 0.000 claims description 15
OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 claims description 14
MUMGGOZAMZWBJJ-DYKIIFRCSA-N Testostosterone Chemical compound O=C1CC[C@]2(C)[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 MUMGGOZAMZWBJJ-DYKIIFRCSA-N 0.000 claims description 14
230000000694 effects Effects 0.000 claims description 14
235000019152 folic acid Nutrition 0.000 claims description 14
230000009871 nonspecific binding Effects 0.000 claims description 14
239000000598 endocrine disruptor Substances 0.000 claims description 13
239000010954 inorganic particle Substances 0.000 claims description 13
239000011148 porous material Substances 0.000 claims description 13
239000002794 2,4-DB Substances 0.000 claims description 12
239000005944 Chlorpyrifos Substances 0.000 claims description 12
ZNZYKNKBJPZETN-WELNAUFTSA-N Dialdehyde 11678 Chemical compound N1C2=CC=CC=C2C2=C1[C@H](C[C@H](/C(=C/O)C(=O)OC)[C@@H](C=C)C=O)NCC2 ZNZYKNKBJPZETN-WELNAUFTSA-N 0.000 claims description 12
239000002098 aflatoxin G1 Substances 0.000 claims description 12
DNXHEGUUPJUMQT-UHFFFAOYSA-N (+)-estrone Natural products OC1=CC=C2C3CCC(C)(C(CC4)=O)C4C3CCC2=C1 DNXHEGUUPJUMQT-UHFFFAOYSA-N 0.000 claims description 10
102000015694 estrogen receptors Human genes 0.000 claims description 10
108010038795 estrogen receptors Proteins 0.000 claims description 10
239000003559 2,4,5-trichlorophenoxyacetic acid Substances 0.000 claims description 9
239000005631 2,4-Dichlorophenoxyacetic acid Substances 0.000 claims description 9
231100000678 Mycotoxin Toxicity 0.000 claims description 9
LUBJCRLGQSPQNN-UHFFFAOYSA-N Z-phenylurea Natural products NC(=O)NC1=CC=CC=C1 LUBJCRLGQSPQNN-UHFFFAOYSA-N 0.000 claims description 9
239000002092 aflatoxin Q1 Substances 0.000 claims description 9
230000000356 anti-lactoferrin effect Effects 0.000 claims description 9
230000001076 estrogenic effect Effects 0.000 claims description 9
238000012986 modification Methods 0.000 claims description 9
230000004048 modification Effects 0.000 claims description 9
239000002636 mycotoxin Substances 0.000 claims description 9
229930166256 Aflatoxin G2 Natural products 0.000 claims description 8
DNXHEGUUPJUMQT-CBZIJGRNSA-N Estrone Chemical compound OC1=CC=C2[C@H]3CC[C@](C)(C(CC4)=O)[C@@H]4[C@@H]3CCC2=C1 DNXHEGUUPJUMQT-CBZIJGRNSA-N 0.000 claims description 8
SXRSQZLOMIGNAQ-UHFFFAOYSA-N Glutaraldehyde Chemical compound O=CCCCC=O SXRSQZLOMIGNAQ-UHFFFAOYSA-N 0.000 claims description 8
FSCWZHGZWWDELK-UHFFFAOYSA-N 3-(3,5-dichlorophenyl)-5-ethenyl-5-methyl-2,4-oxazolidinedione Chemical compound O=C1C(C)(C=C)OC(=O)N1C1=CC(Cl)=CC(Cl)=C1 FSCWZHGZWWDELK-UHFFFAOYSA-N 0.000 claims description 7
SJECZPVISLOESU-UHFFFAOYSA-N 3-trimethoxysilylpropan-1-amine Chemical compound CO[Si](OC)(OC)CCCN SJECZPVISLOESU-UHFFFAOYSA-N 0.000 claims description 7
229930132918 Aflatoxin B2 Natural products 0.000 claims description 7
WPCVRWVBBXIRMA-WNWIJWBNSA-N Aflatoxin G2 Chemical compound O=C1OCCC2=C1C(=O)OC1=C2C(OC)=CC2=C1[C@@H]1CCO[C@@H]1O2 WPCVRWVBBXIRMA-WNWIJWBNSA-N 0.000 claims description 7
WWSYXEZEXMQWHT-WNWIJWBNSA-N aflatoxin B2 Chemical compound C=1([C@@H]2CCO[C@@H]2OC=1C=C(C1=2)OC)C=2OC(=O)C2=C1CCC2=O WWSYXEZEXMQWHT-WNWIJWBNSA-N 0.000 claims description 7
230000027455 binding Effects 0.000 claims description 7
238000004007 reversed phase HPLC Methods 0.000 claims description 7
UCTWMZQNUQWSLP-VIFPVBQESA-N (R)-adrenaline Chemical compound CNC[C@H](O)C1=CC=C(O)C(O)=C1 UCTWMZQNUQWSLP-VIFPVBQESA-N 0.000 claims description 6
BFPYWIDHMRZLRN-SLHNCBLASA-N Ethinyl estradiol Chemical compound OC1=CC=C2[C@H]3CC[C@](C)([C@](CC4)(O)C#C)[C@@H]4[C@@H]3CCC2=C1 BFPYWIDHMRZLRN-SLHNCBLASA-N 0.000 claims description 6
108010063045 Lactoferrin Proteins 0.000 claims description 6
102000010445 Lactoferrin Human genes 0.000 claims description 6
VYFYYTLLBUKUHU-UHFFFAOYSA-N dopamine Chemical compound NCCC1=CC=C(O)C(O)=C1 VYFYYTLLBUKUHU-UHFFFAOYSA-N 0.000 claims description 6
CSSYQJWUGATIHM-IKGCZBKSSA-N l-phenylalanyl-l-lysyl-l-cysteinyl-l-arginyl-l-arginyl-l-tryptophyl-l-glutaminyl-l-tryptophyl-l-arginyl-l-methionyl-l-lysyl-l-lysyl-l-leucylglycyl-l-alanyl-l-prolyl-l-seryl-l-isoleucyl-l-threonyl-l-cysteinyl-l-valyl-l-arginyl-l-arginyl-l-alanyl-l-phenylal Chemical compound C([C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CS)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(O)=O)C1=CC=CC=C1 CSSYQJWUGATIHM-IKGCZBKSSA-N 0.000 claims description 6
229940078795 lactoferrin Drugs 0.000 claims description 6
235000021242 lactoferrin Nutrition 0.000 claims description 6
NPAGDVCDWIYMMC-IZPLOLCNSA-N nandrolone Chemical compound O=C1CC[C@@H]2[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 NPAGDVCDWIYMMC-IZPLOLCNSA-N 0.000 claims description 6
VOXZDWNPVJITMN-ZBRFXRBCSA-N 17β-estradiol Chemical compound OC1=CC=C2[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 VOXZDWNPVJITMN-ZBRFXRBCSA-N 0.000 claims description 5
UCTWMZQNUQWSLP-UHFFFAOYSA-N Adrenaline Natural products CNCC(O)C1=CC=C(O)C(O)=C1 UCTWMZQNUQWSLP-UHFFFAOYSA-N 0.000 claims description 5
WMLPCIHUFDKWJU-UHFFFAOYSA-N Cinosulfuron Chemical compound COCCOC1=CC=CC=C1S(=O)(=O)NC(=O)NC1=NC(OC)=NC(OC)=N1 WMLPCIHUFDKWJU-UHFFFAOYSA-N 0.000 claims description 5
239000005581 Metobromuron Substances 0.000 claims description 5
WLFDQEVORAMCIM-UHFFFAOYSA-N Metobromuron Chemical compound CON(C)C(=O)NC1=CC=C(Br)C=C1 WLFDQEVORAMCIM-UHFFFAOYSA-N 0.000 claims description 5
239000005604 Prosulfuron Substances 0.000 claims description 5
LTUNNEGNEKBSEH-UHFFFAOYSA-N Prosulfuron Chemical compound COC1=NC(C)=NC(NC(=O)NS(=O)(=O)C=2C(=CC=CC=2)CCC(F)(F)F)=N1 LTUNNEGNEKBSEH-UHFFFAOYSA-N 0.000 claims description 5
239000002115 aflatoxin B1 Substances 0.000 claims description 5
150000001299 aldehydes Chemical group 0.000 claims description 5
229960002568 ethinylestradiol Drugs 0.000 claims description 5
238000004519 manufacturing process Methods 0.000 claims description 5
230000009257 reactivity Effects 0.000 claims description 5
XOPFESVZMSQIKC-UHFFFAOYSA-N triasulfuron Chemical compound COC1=NC(C)=NC(NC(=O)NS(=O)(=O)C=2C(=CC=CC=2)OCCCl)=N1 XOPFESVZMSQIKC-UHFFFAOYSA-N 0.000 claims description 5
SFLSHLFXELFNJZ-QMMMGPOBSA-N (-)-norepinephrine Chemical compound NC[C@H](O)C1=CC=C(O)C(O)=C1 SFLSHLFXELFNJZ-QMMMGPOBSA-N 0.000 claims description 4
102000007056 Recombinant Fusion Proteins Human genes 0.000 claims description 4
108010008281 Recombinant Fusion Proteins Proteins 0.000 claims description 4
SBPBAQFWLVIOKP-UHFFFAOYSA-N chlorpyrifos Chemical compound CCOP(=S)(OCC)OC1=NC(Cl)=C(Cl)C=C1Cl SBPBAQFWLVIOKP-UHFFFAOYSA-N 0.000 claims description 4
229960003638 dopamine Drugs 0.000 claims description 4
ZNOLGFHPUIJIMJ-UHFFFAOYSA-N fenitrothion Chemical compound COP(=S)(OC)OC1=CC=C([N+]([O-])=O)C(C)=C1 ZNOLGFHPUIJIMJ-UHFFFAOYSA-N 0.000 claims description 4
238000011049 filling Methods 0.000 claims description 4
238000007789 sealing Methods 0.000 claims description 4
YIVXMZJTEQBPQO-UHFFFAOYSA-N 2,4-DB Chemical compound OC(=O)CCCOC1=CC=C(Cl)C=C1Cl YIVXMZJTEQBPQO-UHFFFAOYSA-N 0.000 claims description 3
229940102884 adrenalin Drugs 0.000 claims description 3
230000004071 biological effect Effects 0.000 claims description 3
238000001917 fluorescence detection Methods 0.000 claims description 3
SMYMJHWAQXWPDB-UHFFFAOYSA-N (2,4,5-trichlorophenoxy)acetic acid Chemical compound OC(=O)COC1=CC(Cl)=C(Cl)C=C1Cl SMYMJHWAQXWPDB-UHFFFAOYSA-N 0.000 claims description 2
OVSKIKFHRZPJSS-DOMIDYPGSA-N 2-(2,4-dichlorophenoxy)acetic acid Chemical compound OC(=O)[14CH2]OC1=CC=C(Cl)C=C1Cl OVSKIKFHRZPJSS-DOMIDYPGSA-N 0.000 claims description 2
238000011010 flushing procedure Methods 0.000 claims description 2
239000012488 sample solution Substances 0.000 claims description 2
125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims 8
VOXZDWNPVJITMN-UHFFFAOYSA-N 13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-3,17-diol Chemical compound OC1=CC=C2C3CCC(C)(C(CC4)O)C4C3CCC2=C1 VOXZDWNPVJITMN-UHFFFAOYSA-N 0.000 claims 1
XWIYFDMXXLINPU-WNWIJWBNSA-N Aflatoxin G1 Chemical compound O=C1OCCC2=C1C(=O)OC1=C2C(OC)=CC2=C1[C@@H]1C=CO[C@@H]1O2 XWIYFDMXXLINPU-WNWIJWBNSA-N 0.000 claims 1
229930063498 Aflatoxin G1 Natural products 0.000 claims 1
AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 claims 1
150000001412 amines Chemical class 0.000 claims 1
239000002904 solvent Substances 0.000 claims 1
125000005647 linker group Chemical group 0.000 description 46
239000000872 buffer Substances 0.000 description 44
WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 36
FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 36
OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 33
239000000203 mixture Substances 0.000 description 26
239000012149 elution buffer Substances 0.000 description 20
239000000126 substance Substances 0.000 description 20
239000011780 sodium chloride Substances 0.000 description 18
PXIPVTKHYLBLMZ-UHFFFAOYSA-N Sodium azide Chemical compound [Na+].[N-]=[N+]=[N-] PXIPVTKHYLBLMZ-UHFFFAOYSA-N 0.000 description 16
239000012148 binding buffer Substances 0.000 description 16
238000004128 high performance liquid chromatography Methods 0.000 description 16
229910044991 metal oxide Inorganic materials 0.000 description 16
150000004706 metal oxides Chemical class 0.000 description 16
239000000377 silicon dioxide Substances 0.000 description 15
YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 12
125000004429 atom Chemical group 0.000 description 10
239000000376 reactant Substances 0.000 description 10
229910019142 PO4 Inorganic materials 0.000 description 9
LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 9
239000002953 phosphate buffered saline Substances 0.000 description 9
239000002699 waste material Substances 0.000 description 9
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 9
238000005516 engineering process Methods 0.000 description 8
125000002887 hydroxy group Chemical group [H]O* 0.000 description 8
NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 8
239000010452 phosphate Substances 0.000 description 8
238000002360 preparation method Methods 0.000 description 8
239000007787 solid Substances 0.000 description 8
239000004009 herbicide Substances 0.000 description 7
HZAXFHJVJLSVMW-UHFFFAOYSA-N 2-Aminoethan-1-ol Chemical compound NCCO HZAXFHJVJLSVMW-UHFFFAOYSA-N 0.000 description 6
IRIAEXORFWYRCZ-UHFFFAOYSA-N Butylbenzyl phthalate Chemical compound CCCCOC(=O)C1=CC=CC=C1C(=O)OCC1=CC=CC=C1 IRIAEXORFWYRCZ-UHFFFAOYSA-N 0.000 description 6
238000004458 analytical method Methods 0.000 description 6
238000001514 detection method Methods 0.000 description 6
229960005309 estradiol Drugs 0.000 description 6
230000002363 herbicidal effect Effects 0.000 description 6
229910052809 inorganic oxide Inorganic materials 0.000 description 6
239000007788 liquid Substances 0.000 description 6
239000000047 product Substances 0.000 description 6
235000005956 Cosmos caudatus Nutrition 0.000 description 5
241000282414 Homo sapiens Species 0.000 description 5
VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 5
241001465754 Metazoa Species 0.000 description 5
239000004696 Poly ether ether ketone Substances 0.000 description 5
125000003636 chemical group Chemical group 0.000 description 5
238000006243 chemical reaction Methods 0.000 description 5
238000011068 loading method Methods 0.000 description 5
229910052751 metal Inorganic materials 0.000 description 5
239000002184 metal Substances 0.000 description 5
229920002530 polyetherether ketone Polymers 0.000 description 5
239000002243 precursor Substances 0.000 description 5
229940088594 vitamin Drugs 0.000 description 5
229930003231 vitamin Natural products 0.000 description 5
235000013343 vitamin Nutrition 0.000 description 5
239000011782 vitamin Substances 0.000 description 5
150000003722 vitamin derivatives Chemical class 0.000 description 5
239000003643 water by type Substances 0.000 description 5
VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 4
239000012472 biological sample Substances 0.000 description 4
125000000392 cycloalkenyl group Chemical group 0.000 description 4
229930182833 estradiol Natural products 0.000 description 4
238000010438 heat treatment Methods 0.000 description 4
238000002347 injection Methods 0.000 description 4
239000007924 injection Substances 0.000 description 4
239000001632 sodium acetate Substances 0.000 description 4
235000017281 sodium acetate Nutrition 0.000 description 4
238000001179 sorption measurement Methods 0.000 description 4
239000002352 surface water Substances 0.000 description 4
HNSDLXPSAYFUHK-UHFFFAOYSA-N 1,4-bis(2-ethylhexyl) sulfosuccinate Chemical compound CCCCC(CC)COC(=O)CC(S(O)(=O)=O)C(=O)OCC(CC)CCCC HNSDLXPSAYFUHK-UHFFFAOYSA-N 0.000 description 3
VOXZDWNPVJITMN-SFFUCWETSA-N 17α-estradiol Chemical compound OC1=CC=C2[C@H]3CC[C@](C)([C@@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 VOXZDWNPVJITMN-SFFUCWETSA-N 0.000 description 3
HABAPWZXRLIZDL-UHFFFAOYSA-N 2-chloro-2-phenoxyacetic acid Chemical compound OC(=O)C(Cl)OC1=CC=CC=C1 HABAPWZXRLIZDL-UHFFFAOYSA-N 0.000 description 3
LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 3
XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical group [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 3
PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 3
125000003710 aryl alkyl group Chemical group 0.000 description 3
239000013060 biological fluid Substances 0.000 description 3
238000010276 construction Methods 0.000 description 3
230000007613 environmental effect Effects 0.000 description 3
235000013305 food Nutrition 0.000 description 3
238000004811 liquid chromatography Methods 0.000 description 3
238000012856 packing Methods 0.000 description 3
239000008055 phosphate buffer solution Substances 0.000 description 3
230000008569 process Effects 0.000 description 3
235000018102 proteins Nutrition 0.000 description 3
102000004169 proteins and genes Human genes 0.000 description 3
108090000623 proteins and genes Proteins 0.000 description 3
102000005962 receptors Human genes 0.000 description 3
108020003175 receptors Proteins 0.000 description 3
229910052710 silicon Inorganic materials 0.000 description 3
239000011734 sodium Substances 0.000 description 3
238000003860 storage Methods 0.000 description 3
YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
229930037703 Aflatoxin Q1 Natural products 0.000 description 2
DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
ZRALSGWEFCBTJO-UHFFFAOYSA-N Guanidine Chemical compound NC(N)=N ZRALSGWEFCBTJO-UHFFFAOYSA-N 0.000 description 2
IGFHQQFPSIBGKE-UHFFFAOYSA-N Nonylphenol Natural products CCCCCCCCCC1=CC=C(O)C=C1 IGFHQQFPSIBGKE-UHFFFAOYSA-N 0.000 description 2
GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 2
XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 2
MCMNRKCIXSYSNV-UHFFFAOYSA-N Zirconium dioxide Chemical compound O=[Zr]=O MCMNRKCIXSYSNV-UHFFFAOYSA-N 0.000 description 2
125000003342 alkenyl group Chemical group 0.000 description 2
125000000217 alkyl group Chemical group 0.000 description 2
125000000304 alkynyl group Chemical group 0.000 description 2
239000007864 aqueous solution Substances 0.000 description 2
125000003118 aryl group Chemical group 0.000 description 2
125000000732 arylene group Chemical group 0.000 description 2
230000008901 benefit Effects 0.000 description 2
238000009835 boiling Methods 0.000 description 2
125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 description 2
239000011248 coating agent Substances 0.000 description 2
238000011109 contamination Methods 0.000 description 2
239000005289 controlled pore glass Substances 0.000 description 2
125000005724 cycloalkenylene group Chemical group 0.000 description 2
125000000753 cycloalkyl group Chemical group 0.000 description 2
230000002124 endocrine Effects 0.000 description 2
231100000049 endocrine disruptor Toxicity 0.000 description 2
210000000750 endocrine system Anatomy 0.000 description 2
235000013350 formula milk Nutrition 0.000 description 2
239000011521 glass Substances 0.000 description 2
239000003673 groundwater Substances 0.000 description 2
125000000623 heterocyclic group Chemical group 0.000 description 2
230000003993 interaction Effects 0.000 description 2
SNQQPOLDUKLAAF-UHFFFAOYSA-N nonylphenol Chemical compound CCCCCCCCCC1=CC=CC=C1O SNQQPOLDUKLAAF-UHFFFAOYSA-N 0.000 description 2
239000005022 packaging material Substances 0.000 description 2
229920000642 polymer Polymers 0.000 description 2
IOLCXVTUBQKXJR-UHFFFAOYSA-M potassium bromide Chemical compound [K+].[Br-] IOLCXVTUBQKXJR-UHFFFAOYSA-M 0.000 description 2
238000000926 separation method Methods 0.000 description 2
210000002966 serum Anatomy 0.000 description 2
239000010703 silicon Substances 0.000 description 2
239000010802 sludge Substances 0.000 description 2
239000011343 solid material Substances 0.000 description 2
239000008247 solid mixture Substances 0.000 description 2
239000003270 steroid hormone Substances 0.000 description 2
125000005017 substituted alkenyl group Chemical group 0.000 description 2
125000000547 substituted alkyl group Chemical group 0.000 description 2
125000004426 substituted alkynyl group Chemical group 0.000 description 2
125000003107 substituted aryl group Chemical group 0.000 description 2
125000005346 substituted cycloalkyl group Chemical group 0.000 description 2
238000003786 synthesis reaction Methods 0.000 description 2
239000008399 tap water Substances 0.000 description 2
235000020679 tap water Nutrition 0.000 description 2
210000002700 urine Anatomy 0.000 description 2
238000005303 weighing Methods 0.000 description 2
IAKOZHOLGAGEJT-UHFFFAOYSA-N 1,1,1-trichloro-2,2-bis(p-methoxyphenyl)-Ethane Chemical compound C1=CC(OC)=CC=C1C(C(Cl)(Cl)Cl)C1=CC=C(OC)C=C1 IAKOZHOLGAGEJT-UHFFFAOYSA-N 0.000 description 1
RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 1
HFGHRUCCKVYFKL-UHFFFAOYSA-N 4-ethoxy-2-piperazin-1-yl-7-pyridin-4-yl-5h-pyrimido[5,4-b]indole Chemical compound C1=C2NC=3C(OCC)=NC(N4CCNCC4)=NC=3C2=CC=C1C1=CC=NC=C1 HFGHRUCCKVYFKL-UHFFFAOYSA-N 0.000 description 1
108090001008 Avidin Proteins 0.000 description 1
229930185605 Bisphenol Natural products 0.000 description 1
241000283690 Bos taurus Species 0.000 description 1
OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
235000006693 Cassia laevigata Nutrition 0.000 description 1
244000060011 Cocos nucifera Species 0.000 description 1
235000013162 Cocos nucifera Nutrition 0.000 description 1
240000007154 Coffea arabica Species 0.000 description 1
YVGGHNCTFXOJCH-UHFFFAOYSA-N DDT Chemical compound C1=CC(Cl)=CC=C1C(C(Cl)(Cl)Cl)C1=CC=C(Cl)C=C1 YVGGHNCTFXOJCH-UHFFFAOYSA-N 0.000 description 1
239000004471 Glycine Substances 0.000 description 1
241000282412 Homo Species 0.000 description 1
CHJJGSNFBQVOTG-UHFFFAOYSA-N N-methyl-guanidine Natural products CNC(N)=N CHJJGSNFBQVOTG-UHFFFAOYSA-N 0.000 description 1
GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 description 1
BPQQTUXANYXVAA-UHFFFAOYSA-N Orthosilicate Chemical compound [O-][Si]([O-])([O-])[O-] BPQQTUXANYXVAA-UHFFFAOYSA-N 0.000 description 1
239000004743 Polypropylene Substances 0.000 description 1
241000522641 Senna Species 0.000 description 1
241000270295 Serpentes Species 0.000 description 1
BLRPTPMANUNPDV-UHFFFAOYSA-N Silane Chemical compound [SiH4] BLRPTPMANUNPDV-UHFFFAOYSA-N 0.000 description 1
108010090804 Streptavidin Proteins 0.000 description 1
244000299461 Theobroma cacao Species 0.000 description 1
235000009470 Theobroma cacao Nutrition 0.000 description 1
QCWXUUIWCKQGHC-UHFFFAOYSA-N Zirconium Chemical compound [Zr] QCWXUUIWCKQGHC-UHFFFAOYSA-N 0.000 description 1
239000002253 acid Substances 0.000 description 1
230000009471 action Effects 0.000 description 1
GYNOTJLCULOEIM-XKRJZGAWSA-N aflatoxin Q1 Chemical compound C=1([C@@H]2C=CO[C@@H]2OC=1C=C(C1=2)OC)C=2OC(=O)C2=C1[C@@H](O)CC2=O GYNOTJLCULOEIM-XKRJZGAWSA-N 0.000 description 1
229930020125 aflatoxin-B1 Natural products 0.000 description 1
230000004075 alteration Effects 0.000 description 1
229910052782 aluminium Inorganic materials 0.000 description 1
XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
229910000323 aluminium silicate Inorganic materials 0.000 description 1
239000005354 aluminosilicate glass Substances 0.000 description 1
239000000427 antigen Substances 0.000 description 1
102000036639 antigens Human genes 0.000 description 1
108091007433 antigens Proteins 0.000 description 1
235000013405 beer Nutrition 0.000 description 1
230000015572 biosynthetic process Effects 0.000 description 1
229960002685 biotin Drugs 0.000 description 1
235000020958 biotin Nutrition 0.000 description 1
239000011616 biotin Substances 0.000 description 1
229940106691 bisphenol a Drugs 0.000 description 1
239000004202 carbamide Substances 0.000 description 1
229910052799 carbon Inorganic materials 0.000 description 1
238000005341 cation exchange Methods 0.000 description 1
235000013339 cereals Nutrition 0.000 description 1
239000003795 chemical substances by application Substances 0.000 description 1
238000004587 chromatography analysis Methods 0.000 description 1
239000012501 chromatography medium Substances 0.000 description 1
239000003245 coal Substances 0.000 description 1
235000016213 coffee Nutrition 0.000 description 1
235000013353 coffee beverage Nutrition 0.000 description 1
125000002993 cycloalkylene group Chemical group 0.000 description 1
239000008367 deionised water Substances 0.000 description 1
229910021641 deionized water Inorganic materials 0.000 description 1
230000002939 deleterious effect Effects 0.000 description 1
RGLYKWWBQGJZGM-ISLYRVAYSA-N diethylstilbestrol Chemical compound C=1C=C(O)C=CC=1C(/CC)=C(\CC)C1=CC=C(O)C=C1 RGLYKWWBQGJZGM-ISLYRVAYSA-N 0.000 description 1
229960000452 diethylstilbestrol Drugs 0.000 description 1
SWSQBOPZIKWTGO-UHFFFAOYSA-N dimethylaminoamidine Natural products CN(C)C(N)=N SWSQBOPZIKWTGO-UHFFFAOYSA-N 0.000 description 1
HNPSIPDUKPIQMN-UHFFFAOYSA-N dioxosilane;oxo(oxoalumanyloxy)alumane Chemical compound O=[Si]=O.O=[Al]O[Al]=O HNPSIPDUKPIQMN-UHFFFAOYSA-N 0.000 description 1
KPUWHANPEXNPJT-UHFFFAOYSA-N disiloxane Chemical class [SiH3]O[SiH3] KPUWHANPEXNPJT-UHFFFAOYSA-N 0.000 description 1
235000011869 dried fruits Nutrition 0.000 description 1
238000001035 drying Methods 0.000 description 1
230000008030 elimination Effects 0.000 description 1
238000003379 elimination reaction Methods 0.000 description 1
238000010828 elution Methods 0.000 description 1
239000000284 extract Substances 0.000 description 1
239000000835 fiber Substances 0.000 description 1
239000012065 filter cake Substances 0.000 description 1
238000009472 formulation Methods 0.000 description 1
239000012634 fragment Substances 0.000 description 1
230000006870 function Effects 0.000 description 1
239000000499 gel Substances 0.000 description 1
229940045109 genistein Drugs 0.000 description 1
TZBJGXHYKVUXJN-UHFFFAOYSA-N genistein Natural products C1=CC(O)=CC=C1C1=COC2=CC(O)=CC(O)=C2C1=O TZBJGXHYKVUXJN-UHFFFAOYSA-N 0.000 description 1
235000006539 genistein Nutrition 0.000 description 1
ZCOLJUOHXJRHDI-CMWLGVBASA-N genistein 7-O-beta-D-glucoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC(O)=C2C(=O)C(C=3C=CC(O)=CC=3)=COC2=C1 ZCOLJUOHXJRHDI-CMWLGVBASA-N 0.000 description 1
230000036541 health Effects 0.000 description 1
230000008821 health effect Effects 0.000 description 1
235000008216 herbs Nutrition 0.000 description 1
230000013632 homeostatic process Effects 0.000 description 1
230000003054 hormonal effect Effects 0.000 description 1
229940088597 hormone Drugs 0.000 description 1
239000005556 hormone Substances 0.000 description 1
125000001183 hydrocarbyl group Chemical group 0.000 description 1
125000004435 hydrogen atom Chemical group [H]* 0.000 description 1
230000007062 hydrolysis Effects 0.000 description 1
238000006460 hydrolysis reaction Methods 0.000 description 1
230000002209 hydrophobic effect Effects 0.000 description 1
125000004029 hydroxymethyl group Chemical group [H]OC([H])([H])* 0.000 description 1
239000003317 industrial substance Substances 0.000 description 1
229910010272 inorganic material Inorganic materials 0.000 description 1
239000011147 inorganic material Substances 0.000 description 1
230000002452 interceptive effect Effects 0.000 description 1
230000001788 irregular Effects 0.000 description 1
239000006249 magnetic particle Substances 0.000 description 1
238000012423 maintenance Methods 0.000 description 1
230000004060 metabolic process Effects 0.000 description 1
229910052914 metal silicate Inorganic materials 0.000 description 1
150000002739 metals Chemical class 0.000 description 1
229910017604 nitric acid Inorganic materials 0.000 description 1
229960002748 norepinephrine Drugs 0.000 description 1
SFLSHLFXELFNJZ-UHFFFAOYSA-N norepinephrine Natural products NCC(O)C1=CC=C(O)C(O)=C1 SFLSHLFXELFNJZ-UHFFFAOYSA-N 0.000 description 1
102000039446 nucleic acids Human genes 0.000 description 1
108020004707 nucleic acids Proteins 0.000 description 1
150000007523 nucleic acids Chemical class 0.000 description 1
125000002524 organometallic group Chemical group 0.000 description 1
239000000575 pesticide Substances 0.000 description 1
239000008194 pharmaceutical composition Substances 0.000 description 1
239000004033 plastic Substances 0.000 description 1
229920001155 polypropylene Polymers 0.000 description 1
ZNNZYHKDIALBAK-UHFFFAOYSA-M potassium thiocyanate Chemical compound [K+].[S-]C#N ZNNZYHKDIALBAK-UHFFFAOYSA-M 0.000 description 1
229940116357 potassium thiocyanate Drugs 0.000 description 1
239000002244 precipitate Substances 0.000 description 1
108090000765 processed proteins & peptides Proteins 0.000 description 1
125000006239 protecting group Chemical group 0.000 description 1
230000001681 protective effect Effects 0.000 description 1
230000011371 regulation of developmental process Effects 0.000 description 1
238000011160 research Methods 0.000 description 1
238000012552 review Methods 0.000 description 1
238000012502 risk assessment Methods 0.000 description 1
229940124513 senna glycoside Drugs 0.000 description 1
IPQVTOJGNYVQEO-KGFNBKMBSA-N sennoside A Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=CC2=C1C(=O)C1=C(O)C=C(C(O)=O)C=C1[C@@H]2[C@H]1C2=CC(C(O)=O)=CC(O)=C2C(=O)C2=C(O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O3)O)C=CC=C21 IPQVTOJGNYVQEO-KGFNBKMBSA-N 0.000 description 1
230000035945 sensitivity Effects 0.000 description 1
229910000077 silane Inorganic materials 0.000 description 1
235000013599 spices Nutrition 0.000 description 1
229910001220 stainless steel Inorganic materials 0.000 description 1
239000010935 stainless steel Substances 0.000 description 1
239000011550 stock solution Substances 0.000 description 1
125000005717 substituted cycloalkylene group Chemical group 0.000 description 1
239000006228 supernatant Substances 0.000 description 1
125000002813 thiocarbonyl group Chemical group *C(*)=S 0.000 description 1
MBMQEIFVQACCCH-UHFFFAOYSA-N trans-Zearalenon Natural products O=C1OC(C)CCCC(=O)CCCC=CC2=CC(O)=CC(O)=C21 MBMQEIFVQACCCH-UHFFFAOYSA-N 0.000 description 1
230000009466 transformation Effects 0.000 description 1
238000000844 transformation Methods 0.000 description 1
230000032258 transport Effects 0.000 description 1
CSDVDSUBFYNSMC-UHFFFAOYSA-N triethoxysilylmethyl acetate Chemical compound CCO[Si](OCC)(OCC)COC(C)=O CSDVDSUBFYNSMC-UHFFFAOYSA-N 0.000 description 1
235000015112 vegetable and seed oil Nutrition 0.000 description 1
239000008158 vegetable oil Substances 0.000 description 1
MBMQEIFVQACCCH-QBODLPLBSA-N zearalenone Chemical compound O=C1O[C@@H](C)CCCC(=O)CCC\C=C\C2=CC(O)=CC(O)=C21 MBMQEIFVQACCCH-QBODLPLBSA-N 0.000 description 1
229910052726 zirconium Inorganic materials 0.000 description 1

Classifications

- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
- B01D15/08—Selective adsorption, e.g. chromatography
- B01D15/10—Selective adsorption, e.g. chromatography characterised by constructional or operational features
- B01D15/18—Selective adsorption, e.g. chromatography characterised by constructional or operational features relating to flow patterns
- B01D15/1864—Selective adsorption, e.g. chromatography characterised by constructional or operational features relating to flow patterns using two or more columns
- B01D15/1871—Selective adsorption, e.g. chromatography characterised by constructional or operational features relating to flow patterns using two or more columns placed in series
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
- B01D15/08—Selective adsorption, e.g. chromatography
- B01D15/26—Selective adsorption, e.g. chromatography characterised by the separation mechanism
- B01D15/38—Selective adsorption, e.g. chromatography characterised by the separation mechanism involving specific interaction not covered by one or more of groups B01D15/265 - B01D15/36
- B01D15/3804—Affinity chromatography
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J20/00—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
- B01J20/281—Sorbents specially adapted for preparative, analytical or investigative chromatography
- B01J20/286—Phases chemically bonded to a substrate, e.g. to silica or to polymers
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J20/00—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
- B01J20/30—Processes for preparing, regenerating, or reactivating
- B01J20/32—Impregnating or coating ; Solid sorbent compositions obtained from processes involving impregnating or coating
- B01J20/3214—Impregnating or coating ; Solid sorbent compositions obtained from processes involving impregnating or coating characterised by the method for obtaining this coating or impregnating
- B01J20/3217—Resulting in a chemical bond between the coating or impregnating layer and the carrier, support or substrate, e.g. a covalent bond
- B01J20/3219—Resulting in a chemical bond between the coating or impregnating layer and the carrier, support or substrate, e.g. a covalent bond involving a particular spacer or linking group, e.g. for attaching an active group
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J20/00—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
- B01J20/30—Processes for preparing, regenerating, or reactivating
- B01J20/32—Impregnating or coating ; Solid sorbent compositions obtained from processes involving impregnating or coating
- B01J20/3231—Impregnating or coating ; Solid sorbent compositions obtained from processes involving impregnating or coating characterised by the coating or impregnating layer
- B01J20/3242—Layers with a functional group, e.g. an affinity material, a ligand, a reactant or a complexing group
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
- G01N30/60—Construction of the column
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2220/00—Aspects relating to sorbent materials
- B01J2220/50—Aspects relating to the use of sorbent or filter aid materials
- B01J2220/54—Sorbents specially adapted for analytical or investigative chromatography
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2220/00—Aspects relating to sorbent materials
- B01J2220/50—Aspects relating to the use of sorbent or filter aid materials
- B01J2220/58—Use in a single column
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
- G01N30/26—Conditioning of the fluid carrier; Flow patterns
- G01N30/38—Flow patterns
- G01N30/46—Flow patterns using more than one column
- G01N30/461—Flow patterns using more than one column with serial coupling of separation columns

Landscapes

Chemical & Material Sciences (AREA)
Analytical Chemistry (AREA)
Health & Medical Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Immunology (AREA)
Life Sciences & Earth Sciences (AREA)
Engineering & Computer Science (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Physics & Mathematics (AREA)
Pathology (AREA)
General Physics & Mathematics (AREA)
Biochemistry (AREA)
Urology & Nephrology (AREA)
Hematology (AREA)
Biomedical Technology (AREA)
Molecular Biology (AREA)
Cell Biology (AREA)
Biotechnology (AREA)
Microbiology (AREA)
Food Science & Technology (AREA)
Medicinal Chemistry (AREA)
Peptides Or Proteins (AREA)
Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Treatment Of Liquids With Adsorbents In General (AREA)
Solid-Sorbent Or Filter-Aiding Compositions (AREA)

ZA200701429A 2004-07-19 2007-02-19 Apparatus components and methods of using apparatus components to detect the presence of an analyte ZA200701429B (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US58907404P	2004-07-19	2004-07-19

Publications (1)

Publication Number	Publication Date
ZA200701429B true ZA200701429B (en)	2008-07-30

Family

ID=35262130

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
ZA200701429A ZA200701429B (en)	2004-07-19	2007-02-19	Apparatus components and methods of using apparatus components to detect the presence of an analyte

Country Status (14)

Country	Link
US (1)	US20080261330A1 (zh)
EP (1)	EP1778377A2 (zh)
JP (1)	JP2008506961A (zh)
KR (1)	KR20070037511A (zh)
CN (1)	CN101031344A (zh)
AU (1)	AU2005263602A1 (zh)
BR (1)	BRPI0513526A (zh)
CA (1)	CA2574634A1 (zh)
IL (1)	IL180800A0 (zh)
MX (1)	MX2007000775A (zh)
NO (1)	NO20070875L (zh)
RU (1)	RU2007105877A (zh)
WO (1)	WO2006008143A2 (zh)
ZA (1)	ZA200701429B (zh)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP2090361A1 (en) *	2008-02-14	2009-08-19	RESQ Lab B.V.	Improved chromatography resin, and methods and devices related thereto.
CN102621340A (zh) *	2012-04-16	2012-08-01	北京莱伯泰科仪器有限公司	一种全自动黄曲霉毒素分析***
CN103743913B (zh) *	2014-01-23	2015-07-08	福建农林大学	快速鉴定与黄曲霉毒素b1互作的宿主蛋白的方法
JP6331485B2 (ja) *	2014-03-04	2018-05-30	株式会社島津製作所	液体クロマトグラフ及び液体クロマトグラフ分析方法
CN104784973A (zh) *	2015-04-24	2015-07-22	重庆出入境检验检疫局检验检疫技术中心	净化***和莱克多巴胺复合免疫亲和柱及其制备方法与应用
CN104931571A (zh) *	2015-06-15	2015-09-23	中国电子工程设计院	一种免疫传感器及其制备方法和2,4-d的检测方法
CN106731007A (zh) *	2017-01-23	2017-05-31	北京美正生物科技有限公司	一种双酚a适配体亲和柱及其制备方法和用途
CN106693443A (zh) *	2017-01-23	2017-05-24	北京美正生物科技有限公司	一种维生素b12适配体亲和柱及其制备方法和用途
CN114041052A (zh) *	2019-06-26	2022-02-11	沃特世科技公司	具有固定的亲和配体和酶的涂层及其在液相色谱测定中的用途
CN112946153B (zh) *	2021-02-03	2022-10-21	仲恺农业工程学院	一种同时测定塑料桶装植物油中多种污染物的方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4298500A (en) *	1980-05-05	1981-11-03	Varian Associates, Inc.	Mixed phase chromatographic compositions
EP0064833B1 (en) *	1981-04-27	1986-06-25	The Public Health Laboratory Service Board	High pressure liquid affinity chromatography
US4818687A (en) *	1985-02-28	1989-04-04	Massachusetts Institute Of Technology	Affinity column and process for detection of low molecular weight toxic substances
AU4800090A (en) *	1988-12-05	1990-06-26	Primus Corporation	Method for determination of glycated proteinaceous species
US5371262A (en) *	1993-03-10	1994-12-06	Gelest, Inc.	Hydroxymethyltrialkoxysilanes and methods of making and using the same
JP3737516B2 (ja) *	1995-06-26	2006-01-18	パーセプティブバイオシステムズ，インコーポレーテッド	高速自動化連続流、多次元分子選別および分析
EP1255603A1 (en)	2000-02-09	2002-11-13	RESQ Lab B.V.	Packing materials for separation of biomolecules
US7691645B2 (en) *	2001-01-09	2010-04-06	Agilent Technologies, Inc.	Immunosubtraction method
US6802966B2 (en) *	2001-08-14	2004-10-12	W. R. Grace & Co. Conn.	Solid compositions for selective adsorption from complex mixtures

2005
- 2005-07-19 BR BRPI0513526-5A patent/BRPI0513526A/pt not_active IP Right Cessation
- 2005-07-19 US US11/660,125 patent/US20080261330A1/en not_active Abandoned
- 2005-07-19 WO PCT/EP2005/007873 patent/WO2006008143A2/en active Application Filing
- 2005-07-19 RU RU2007105877/15A patent/RU2007105877A/ru not_active Application Discontinuation
- 2005-07-19 AU AU2005263602A patent/AU2005263602A1/en not_active Abandoned
- 2005-07-19 CA CA002574634A patent/CA2574634A1/en not_active Abandoned
- 2005-07-19 CN CNA2005800314493A patent/CN101031344A/zh active Pending
- 2005-07-19 MX MX2007000775A patent/MX2007000775A/es unknown
- 2005-07-19 JP JP2007521892A patent/JP2008506961A/ja active Pending
- 2005-07-19 EP EP05763595A patent/EP1778377A2/en not_active Withdrawn
- 2005-07-19 KR KR1020077003777A patent/KR20070037511A/ko not_active Application Discontinuation
2007
- 2007-01-18 IL IL180800A patent/IL180800A0/en unknown
- 2007-02-19 NO NO20070875A patent/NO20070875L/no not_active Application Discontinuation
- 2007-02-19 ZA ZA200701429A patent/ZA200701429B/en unknown

Also Published As

Publication number	Publication date
NO20070875L (no)	2007-04-19
IL180800A0 (en)	2007-07-04
WO2006008143A3 (en)	2006-09-14
JP2008506961A (ja)	2008-03-06
CA2574634A1 (en)	2006-01-26
MX2007000775A (es)	2007-04-02
BRPI0513526A (pt)	2008-05-06
RU2007105877A (ru)	2008-08-27
CN101031344A (zh)	2007-09-05
WO2006008143A2 (en)	2006-01-26
AU2005263602A1 (en)	2006-01-26
US20080261330A1 (en)	2008-10-23
EP1778377A2 (en)	2007-05-02
KR20070037511A (ko)	2007-04-04

Publication	Publication Date	Title
ZA200701429B (en)	2008-07-30	Apparatus components and methods of using apparatus components to detect the presence of an analyte
Delaunay et al.	2000	Immunoaffinity solid-phase extraction for the trace-analysis of low-molecular-mass analytes in complex sample matrices
Hennion et al.	2003	Immuno-based sample preparation for trace analysis
Jiang et al.	2005	Affinity monoliths for ultrafast immunoextraction
Schiel et al.	2006	Applications of silica supports in affinity chromatography
Moser et al.	2010	Immunoaffinity chromatography: an introduction to applications and recent developments
Hennion	1999	Solid-phase extraction: method development, sorbents, and coupling with liquid chromatography
US7166213B2 (en)	2007-01-23	Solid compositions for selective adsorption from complex mixtures
US5545317A (en)	1996-08-13	Liquid column packing materials and method for making the same
US20050100959A1 (en)	2005-05-12	Device and method for detecting the presence of an analyte
US20050029196A1 (en)	2005-02-10	Packing materials for separation of biomolecules
AU2002355940A1 (en)	2003-05-29	Solid compositions for selective adsorption from complex mixtures
EP2434906B1 (en)	2015-10-28	Multi-media affinity column to prevent leaching of ligands
CN107262074A (zh)	2017-10-20	一种脱氧雪腐镰刀菌烯醇适配体亲和柱及其制备方法和用途
Stalikas et al.	2002	Sol− gel glass immunosorbent-based determination of s-triazines in water and soil samples using gas chromatography with a nitrogen phosphorus detection system
Cichna-Markl	2006	Selective sample preparation with bioaffinity columns prepared by the sol–gel method
Pichon et al.	2002	Immunosorbents in sample preparation
Jackson et al.	2012	Principles and applications of immunoaffinity chromatography
EP1255603A1 (en)	2002-11-13	Packing materials for separation of biomolecules
Adlard	1984	Liquid Column Chromatography